"I was at a crossroads—my old age was either going to be one of sitting around or one of exciting adventures." ...

NeuroMetrix’s Quell platform is a cloud-enabled wearable neuromodulation solution intended to treat fibromyalgia symptoms.

First quarter 2025 net sales of $6.7 million, an increase of 23% over first quarter 2024 Closed the acquisition of NeuroMetrix, Inc. (“NeuroMetrix”); first quarter 2025 unaudited Quell net sales of ...

ElectroCore (Nasdaq:ECOR) announced today that it completed its previously announced acquisition of NeuroMetrix  (Nasdaq:NURO ...

A pioneering study has unveiled a revolutionary technique that enhances stem cell therapy for neurodegenerative diseases by ...

Yet that's precisely why FaceGym as a concept is interesting; it's not a facial. If anything, the experience is quite the ...

Bacterial interaction is known for generating electricity, making a new type of batteries possible. There are two main ...

non-invasive nerve stimulation therapies. InvestingPro analysis indicates the stock is currently trading below its Fair Value, suggesting potential upside opportunity for investors. The terms of ...

with a machine used for transcranial magnetic stimulation, which may treat depression and PTSD. For decades we have known that conditions such as severe depression respond well to electro ...